Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
5.87
+0.22 (3.89%)
At close: Nov 22, 2024, 4:00 PM
5.85
-0.02 (-0.34%)
After-hours: Nov 22, 2024, 5:51 PM EST
RGC Market Cap
RGC has a market cap or net worth of $76.39 million as of November 22, 2024. Its market cap has decreased by -63.54% in one year.
Market Cap
76.39M
Enterprise Value
68.51M
1-Year Change
-63.54%
Ranking
Category
Stock Price
$5.87
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has decreased from $120.10M to $76.39M, a decrease of -36.40%. That is a compound annual growth rate of -12.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 73.52M | -46.19% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 76.95M |
| Aerovate Therapeutics | 76.81M |
| CASI Pharmaceuticals | 76.75M |
| I-Mab | 76.59M |
| P3 Health Partners | 76.43M |
| BioAtla | 75.90M |
| SELLAS Life Sciences Group | 75.27M |
| Ovid Therapeutics | 74.56M |